Farmax India Limited announced unaudited standalone earnings results for the second quarter and six months ended September 30, 2015. For the quarter, the company reported total income from operations of INR 57.984 million against INR 39.387 million a year ago. Loss from operations before other income, provisions and exceptional items were INR 16.220 million against INR 29.049 million a year ago. Loss from ordinary activities before tax was INR 15.648 million against INR 28.382 million a year ago. Net loss after taxes, minority interest and share of profit of associates was INR 15.648 million or INR 0.03 per basic and diluted share before and after extraordinary items not annualized against INR 28.382 million or INR 0.07 per basic and diluted share before and after extraordinary items not annualized a year ago.

For the Sox months, the company reported total income from operations of INR 106.174 million against INR 71.366 million a year ago. Loss from operations before other income, provisions and exceptional items were INR 42.195 million against INR 53.541 million a year ago. Loss from ordinary activities before tax was INR 40.789 million against INR 52.295 million a year ago. Net loss after taxes, minority interest and share of profit of associates was INR 40.789 million or INR 0.08 per basic and diluted share before and after extraordinary items not annualized against INR 52.295 million or INR 0.06 per basic and diluted share before and after extraordinary items not annualized a year ago.